MedPath

Mobile Sensing and Support for Depression

Not Applicable
Completed
Conditions
Depression
Interventions
Device: Mobile sensing
Registration Number
NCT02776839
Lead Sponsor
University of Zurich
Brief Summary

The objective of this study is two fold, first to explore the potential of context sensitive intervention delivery to provide in-situ support for people with depressive symptoms, second to explore the detection of daily-life behavior based on smart phone sensor information to identify subjects with a clinically meaningful depression level.

Detailed Description

To conduct a very first pilot trial, a monocentric, single-arm clinical study is conducted. The study is approved by the local ethics committee of the Canton of Zurich in Switzerland and the Swiss Agency for Therapeutic Products. It is conducted in full accordance with the Declaration of Helsinki, with all subjects providing their electronic informed consent prior to participation. As the main interest lies in a proof of concept of the proposed MOSS app, emphasis is put on real life conditions. A range of different recruitment channels is used to attract subjects from the general public; they include physical flyers, online posts on relevant online bulletin boards and the Google Play Store.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
126
Inclusion Criteria
  • self-declaration of depressive symptoms
  • app runs on Android 4.0 and higher
  • germen speaking
Read More
Exclusion Criteria
  • psychotic symptoms
  • bipolar symptoms
  • drug or alcohol dependency
  • dementia
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mobile SensingMobile sensingThis phase of the study is designed to develop the app. due to algorithms the app should lern to detect depressive symptoms
Primary Outcome Measures
NameTimeMethod
Patient Health Questionnaire - for depression (PHQ-9)baseline

subjective depressive symptoms to compare the detected symptoms measured by the app This outcome is needed for the sensing part of the study

Secondary Outcome Measures
NameTimeMethod
Client Satisfaction Questionnaire (ZUF-8)- measures client satisfaction with the appat post (at least 6 weeks after baseline) however some participants will use the app longer than 6 weeks, maximum 6 months

Client satisfaction with the app is assessed

© Copyright 2025. All Rights Reserved by MedPath